Kiltearn Partners’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.68M Buy
102,300
+23,391
+30% +$1.74M 1.8% 19
2025
Q4
$6.25M Sell
78,909
-14,091
-15% -$1.08M 1.35% 22
2025
Q3
$6.79M Sell
93,000
-6,500
-7% -$476K 1.36% 23
2025
Q2
$7.55M Sell
99,500
-1,100
-1% -$77.9K 1.52% 21
2025
Q1
$7.65M Buy
100,600
+27,100
+37% +$2.02M 1.46% 22
2024
Q4
$4.86M Buy
73,500
+32,800
+81% +$2.3M 0.8% 31
2024
Q3
$2.84M Buy
+40,700
New +$2.45M 0.39% 33

Other funds holding SOLV

Kiltearn Partners's SOLV Position: Q1 2026 in Review

Kiltearn Partners increased its Solventum (SOLV) stake by 30% in Q1 2026, buying an estimated $1.74M and bringing the position to 102,300 shares worth $6.68M. The position accounts for 1.8% of the portfolio, ranked #19.

Kiltearn Partners first reported a position in SOLV in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.65M in Q1 2025. 879 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Kiltearn Partners held 102,300 shares of Solventum worth $6.68M as of Q1 2026.
  • Kiltearn Partners bought 23,391 Solventum shares in Q1 2026, an estimated $1.74M.
  • Solventum made up 1.8% of Kiltearn Partners's portfolio in Q1 2026, its #19 holding.
  • Kiltearn Partners first reported a position in Solventum in Q3 2024 and has held it in 7 quarters since.
  • Kiltearn Partners's Solventum position peaked at $7.65M in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.